[HTML][HTML] Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases

…, JM Stempak, D Pereira, D Croitoru, L Acheampong… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Limited information is available on the impact of immunosuppressants on
COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMID). …

Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in adult patients with immune-mediated inflammatory diseases

…, D Croitoru, JM Stempak, L Acheampong… - The Journal of …, 2023 - journals.aai.org
Previous studies have reported impaired humoral responses after SARS-CoV-2 mRNA
vaccination in patients with immune-mediated inflammatory diseases (IMIDs), particularly those …

Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients

…, D Croitoru, JM Stempak, L Acheampong… - medRxiv, 2023 - medrxiv.org
Background Previous studies have reported impaired humoral responses after SARS-CoV-2
mRNA vaccination in immunocompromised patients with immune-mediated inflammatory …

The effects of recreational cannabis use on glycemic outcomes and self-management behaviours in people with type 1 and type 2 diabetes: a rapid review

…, N Darvesh, A Rahman, S Asghari, L Acheampong… - Systematic …, 2020 - Springer
Background Recent surveys of Canadian cannabis users reflect increasing consumption
rates, some of whom may have diabetes. However, healthcare providers have limited …

Examining gender differences in the diagnosis of obstructive airway diseases

L Acheampong - 2019 - research.library.mun.ca
Gender disparities in the diagnosis of cardiovascular diseases have been well established.
Not much is known about gender differences in obstructive airway diseases (OADs). The aim …

Association between early history of asthma and COPD diagnosis in later life: a systematic review and meta-analysis

M Asamoah-Boaheng, L Acheampong… - International journal …, 2018 - academic.oup.com
Background Whereas most studies have reported prior history/diagnosis of asthma as an
independent risk factor for chronic obstructive pulmonary disease (COPD) development in later …

Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases

…, JM Stempak, D Pereira, D Croitoru, L Acheampong… - RMD …, 2022 - rmdopen.bmj.com
Immunocompromised patients treated with immunosuppressive drugs are at increased risk
of adverse outcomes following SARS-CoV-2 infection. 1 There is limited information on the …

Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis

JE Amegadzie, J Gorgui, L Acheampong… - Journal of …, 2021 - Taylor & Francis
Objective To determine the safety and effectiveness of current pharmacotherapies consisting
of long-acting beta 2 -agonist (LABA) and/or inhaled corticosteroids (ICS) in patients with …

[PDF][PDF] The tourism sector, development policy and inequalities in the development of the Eastern Cape

KO Acheampong - 2011 - core.ac.uk
This study on the relations between tourism policies and the tourism development conditions
in the Eastern Cape of South Africa is a contribution to the on-going research projects on …

Antibody and T cell responses to SARS-CoV-2 mRNA vaccines during maintenance therapy for immune-mediated inflammatory diseases

…, JM Stempak, D Pereira, D Croitoru, L Acheampong… - medRxiv, 2022 - medrxiv.org
Background Limited information is available on the impact of immunosuppressants on COVID-19
vaccination in patients with immune-mediated inflammatory diseases (IMID). This study …